Pharmacy

Lack of transparency, lag time in pharmacy being notified of fees create unnecessary burden on pharmacy operations, orgs say.

Pharmacy operators paid kickbacks to doctors for prescribing, refilling pricey compound pain medications, Department of Justice says.

New bill to allow the practice would modify previous safety standards, remove a barrier that blocked previous efforts at importation.

Republican Senators Orrin Hatch, Chuck Grassley, Tom Cotton sent letter to the GAO raising possibility of regulatory, legislative changes.

Premier says leaders will be focused on improving productivity and reducing supply chain inefficiencies and pharmaceutical costs.

Rule may be pushed out to Oct. 1, to give new HHS appointees time to review regulations.

Marathon Pharmaceuticals' controversial $89,000-a-year drug spawned outrage, intense questioning from Congress; new price not yet disclosed.

Former FDA deputy director's connections are expected to be seen as conflicts of interest during confirmation process.

Blue Shield of California wants to create "a tiered pharmacy network" in its 2018 small- and large-group plans, according to preliminary proposals the company submitted to the California Department of Managed Health Care (DMHC), a state health insurance regulator.

Congressmen pitched a House bill that would expand the federal government's ability to negotiate drug prices, and they left feeling optimistic about what Trump will do.